Scientific Conclusions Are All About the Data--Choosing a Logistics Provider For Biomaterial Transport Should Be As Well

Mon, Aug 20, 2018 | By Kirk Randall, Senior Director, Business Development, Cryoport

In our previous blog we discussed key considerations in the transport of critical biomaterials such as cell and gene therapies, in vitro fertilization shipments or large laboratory bio-sample moves.  There we focused on challenges of customs processing, regional or country regulatory requirements and carrier choice and their associated processes.  These are all part of critical risk assessment and mitigation strategies.  Just as the development of the ground-breaking therapies are driven by good scientific methodologies, so should the choice temperature-controlled logistics providers be driven by unbiased data. Whether it be a standard integrator, or a specialty courier, being investigated for utilization data should drive the decision making process.

Monitoring of integrator and specialty courier performance to optimize product delivery and costs

In choosing a logistics partner, an important factor is to find a provider that is carrier agnostic.  So what does that mean?  It means the solution provider is able to use, and track the performance of each carrier.  No one carrier performs at peak levels in all shipping lanes.  An Information Technology (IT) solution that tracks, by shipping lane, the cost, on-time performance and more should be available.  An organization needs to be able choose the optimal carrier for each leg of shipment to ensure the best delivery performance to the end user.  This carrier performance data collection is a key part of the IT solution the logistics solution provider offers to the organization for consideration in carrier or courier choice. The ability to make shipping decisions in this manner allows for best practices in delivery to clients and reduce costs, not only in initial decision making, but on an ongoing basis.  This constant ability to refine temperature-controlled logistics lends the best value and risk mitigation to all involved.  With cell and gene therapies, particularly autologous patient specific therapies, this can mean the difference between life and death.  Risk assessment and ultimately its reduction and mitigation can be greatly improved and enhanced by this unbiased data.

As my colleague mentioned in our last blog posting, key Courier/Carrier considerations include:

  • Does the carrier have experience shipping into this country?
  • Who is responsible for generating accurate airway bills, commercial invoices, and other required documentation?
  • What lanes, airlines, trucking companies will be used?
  • Is one carrier company ideal for all legs of the shipment?
  • Will they support the shipment through customs, or just “drop and go”?
  • What experience do they have with your specific type of biomaterials?

Cryoport via our Cryoportal™ logistics management platform and expert logistics team has this data.  As a carrier agnostic provider of cold chain logistics, we work with nearly every carrier and courier globally.  The Cryoportal™ over the last 9 years has compiled nearly 200,000 legs of shipment data for every carrier or courier we have ever used.  This encompasses 100+ countries.  This data is completely on life science biomaterials of various types. This unequaled database can be mined to create a data driven logistics plan for your shipment(s) or lab moves.  Individual carriers can provide you with data on their history and performance; Cryoport can provide you with data on all carriers or couriers for any shipping lane for any given logistics provider we have ever used their services.  The example below is a typical assessment that Cryoport clients seek and the Cryoportal™ can provide. 

image2       image3

Call us today to see how our consulting team can assist you in planning your critical biomaterial shipments.

From point of origin to destination, Cryoport provides easy ordering, fulfillment, shipping, continuous tracking, condition monitoring, documentation assistance and 24/7/365 customer support for your temperature controlled logistics needs. Cryoport understands the value and impact of your shipments, and is invested in helping you mitigate risk by preserving the integrity of your materials with an easy, reliable, cost-effective and environmentally friendly solution. 

Cryoport...transporting Life.

Written by: Kirk Randall, Sr. Director, Business Development, Cryoport  

Read our blog for the latest news on cold chain logistics issues.

Questions or comments? We welcome your feedback!

Email Us

Tags: Frozen Shipping, frozen shipping solution, Cold Chain Logistics, Cold Chain, Clinical Trials Logistics, Global Cold Chain Logistics, alternative to dry ice shipping, stem cell frozen shipping, regenerative therapies, deep frozen shipping, cellular therapies, Temperature Controlled Logistics, cryogenic shipping, cold chain shipping, biologics, transportation

Cryoport® is a trademark of Cryoport, Inc. and used with permission by Cryoport Systems, LLC